Saladax Biomedical, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Saladax Biomedical, Inc.
Fosun Pharma and Shanghai Pharma have both officially denied their involvement in any bidding battle for German company Stada, although both Chinese firms make no secret of their international expansion ambitions and have been active deal makers in the past.
The number of Chinese IVD companies exhibiting at the 2015 American Association for Clinical Chemistry Annual Meeting (AACC) & Clinical Lab Expo (CLE) was slightly down from last year, but the breadth of diagnostic products and innovations from China appears to be on the up. Hrishi Poola and Jon Chen discuss the moves China is making to become a generator of disruptive technologies and reports on the new products and the players emerging from this market
China’s large-cap pharmaceutical groups have been actively scouting for overseas M&A deals in recent years, with the aims of acquiring advanced technology and bigger global market shares. These cash-rich players’ interest in outbound investment is set to remain high, experts predict.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Therapeutic Drug Monitoring
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.